Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAlbert Einstein College of Medicine

About this trial

The goal of this observational study is to learn about the long-term effects of the serratus anterior plane block (SAPB) in adult patients who suffered multiple unilateral anterolateral rib fractures within 24 hours of patient presentation to the emergency department. The main question it aims to answer is:

Does the SAPB for multiple anterolateral rib fractures demonstrate reduction in patient morbidity and mortality, including incidence of pneumonia, length of hospital stay, discharge disposition, and death, as compared to standard analgesic regimens.

The SAPB will be performed if a physician trained in the SAPB is available within 24 hours of injury. If a trained physician is not available and the patient meets inclusion criteria, they will receive parental analgesia with opioid therapy. They will be followed until date of hospital discharge, up until 60 days.

Eligibility criteria

Qualifiers

Patients over 18 years of age being treated in the Emergency Department at Jacobi Medical Center

Presenting within 24 hours of injury

Patient with 2 or more unilateral, anterior or lateral rib fractures

Able to provide consent (patient or health care proxy)

Disqualifiers

Patients in traumatic arrest or hemodynamic instability

Patient expected to be discharged from the hospital within 24 hours

Prisoner

Pregnancy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

220 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Albert Einstein College of Medicine

Lead sponsor

Jacobi Medical Center

Collaborator